Involvement of cyclooxygenase-2 in hyperplastic gastritis induced by Helicobacter pylori infection in C57BL/6 mice

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 6, 2001, Pages 875-886

  Xiao, F ^a   Furuta, T ^a   Takashima, M ^a   Shirai, N ^a   Hanai, H ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; ETODOLAC; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR;

ANIMALS; CYCLOOXYGENASE 2; DINOPROSTONE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HYPERPLASIA; ISOENZYMES; MALE; MICE; MICE, INBRED C57BL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RISK FACTORS; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 0034988162     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00965.x     Document Type: Article

References (50)

1. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation
2. Helicobacter pylori and peptic ulcers: The present position
3. Helicobacter pylori infection induces gastric cancer in mongolian gerbils
4. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils
5. Helicobacter pylori infection and gastric lymphoma
6. Helicobacter pylori increases proliferation of gastric epithelial cells
7. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy
8. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection
9. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma
10. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement
11. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
12. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo
13. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
14. Prostaglandin endoperoxide synthase: Why two isoforms?
15. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester
16. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages
17. Suppression of intestinal polyposis in APC delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
18. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
19. Elevated cyclooxygenase-2 levels in Min mouse adenomas
20. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
21. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
22. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam
23. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis
24. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection
25. Expression of cyclooxygenase-2 in human gastric carcinoma
26. Aspirin protects against gastric cancer: Results of a case-control study from Moscow, Russia
27. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
28. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain
29. 53 hemizygous transgenic mice
30. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1
31. A method for quantification and correction of proteins after transfer to immobilization membranes
32. Nonsteroidal antiinflammatory drugs could reverse Helicobacter pylori-induced apoptosis and proliferation in gastric epithelial cells
33. The effect of eradicating Helicobacter pylori infection on the course of adenomatous and Hyperplastic gastric polyps
34. Giant fold gastritis - A special form of Helicobacter pylori associated gastritis
35. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease
36. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention
37. Aspirin and the potential role of prostaglandins in colon cancer
38. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
39. Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa
40. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts
41. Expression and localization of cyclooxygenase-2 in normal and ulcerated human gastric mucosa, and in cultured human endothelial cells
42. Immunohistochemical distribution of constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2) in benign and gastric mucosa
43. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils
44. Gastrointestinal mucosal regeneration: Role of growth factors
45. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs
46. 2 and cyclooxygenase-2
47. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells
48. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
49. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
50. 2 and HCF in human gastric fibroblasts